{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 202 - Ben Swanson - CEO of Skeletalis","slug":"episode-202-ben-swanson-ceo-of-skeletalis","published_at":"2026-07-16T14:15:05+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-202-ben-swanson-ceo-of-skeletalis","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-202---Ben-Swanson---CEO-of-Skeletalis-e3m5k30","audio_url":"https://anchor.fm/s/f0076084/podcast/play/122916384/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-6-16%2F428072002-44100-2-804e687564515.mp3","summary":"Today we're joined by Ben Swanson , Founder and CEO of Skeletalis , a biotechnology company developing a new generation of precision medicines for bone disease. Ben's path into biotech is anything but conventional. Trained as both a dentist and a scientist, he founded Skeletalis to tackle one of the biggest unmet challenges in musculoskeletal health: how to deliver treatments directly to the parts of the skeleton that need them most, while minimizing effects on the rest of the body. At Skeletalis, Ben and his team have developed the OASIS platform —a targeted drug delivery approach designed to direct therapies to sites of active bone remodeling. Their lead focus is osteoporosis, a disease affecting hundreds of millions of people worldwide, with the potential to transform how bone diseases are treated in the future. In this conversation, we'll explore Ben's journey from academia to entrepreneurship, what it takes to build a biotech company from groundbreaking research, the future of precision medicine, and why solving bone health could have a profound impact on healthy aging","meta_description":"Today we're joined by Ben Swanson , Founder and CEO of Skeletalis , a biotechnology company developing a new generation of precision medicines for bone di…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2013,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-202-ben-swanson-ceo-of-skeletalis/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-202-ben-swanson-ceo-of-skeletalis.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}